KONZENTRIERTE WÄSSRIGE AZALIDFORMULIERUNGEN
European patent · EP2968383 · Deleted
Register entry
- Publication number
- EP2968383
- Application number
- EP14767754
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 7, 2014
- Published
- Jan 20, 2016
- Granted
- May 8, 2019
- Deleted
- Mar 31, 2020
- Reason
- Annual fee unpaid
- IPC classes
- A61K 31/7052 (2006.01)A61K 31/573 (2006.01)A61P 27/02 (2006.01)A61K 47/02 (2006.01)A61K 47/10 (2017.01)A61K 47/32 (2006.01)A61K 9/08 (2006.01)A61K 47/36 (2006.01)
- Priority
- US 201313843267 15.03.2013
- PCT application
- PCT/US2014/022084 07.03.2014
- PCT publication
- WO2014/150067 25.09.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 21, 2020
Deleted, fee unpaid
Published in Swissreg on 21.10.2020
- Jul 10, 2019
Owner
- Owner
- Insite Vision Incorporated, 965 Atlantic Avenue, Alameda, CA 94501, USA → Sun Pharma Global FZE, Executive Suite Y-43, P.O. Box No.122304, Sharjah, United Arab Emirates
Published in Swissreg on 10.07.2019
- May 8, 2019
Granted
Published in Swissreg on 08.05.2019
Parties
Inventor
HOU, Sui Yuen Eddie
Alameda, CA 94501, US
NGUYEN, Tang
Alameda, CA 94501, US
BOWMAN, Lyle, M.
Alameda, CA 94501, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.